Pembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma
University of California, San Diego
University of California, San Diego
University Health Network, Toronto
University of Pittsburgh
Kura Oncology, Inc.
Alpha Tau Medical LTD.
BeiGene
Vaccinex Inc.
Sun Yat-sen University
The University of Hong Kong
Centre Leon Berard
Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.
Endocyte
H. Lee Moffitt Cancer Center and Research Institute
AIO-Studien-gGmbH
Groupe Oncologie Radiotherapie Tete et Cou
Bristol-Myers Squibb
Institut de Cancérologie de Lorraine
Novartis
UNICANCER
Bristol-Myers Squibb
UNICANCER
AstraZeneca
Pfizer
Incyte Corporation
AstraZeneca
AstraZeneca
UNC Lineberger Comprehensive Cancer Center
Charite University, Berlin, Germany
China Medical University Hospital
Chang Gung Memorial Hospital
Centre Leon Berard
Pierre Fabre Medicament
Daiichi Sankyo
Taipei Veterans General Hospital, Taiwan
University of Zagreb
Groupe Oncologie Radiotherapie Tete et Cou
University of Alabama at Birmingham
Centre Henri Becquerel
University Health Network, Toronto
Oncolytics Biotech
Stanford University
Sun Yat-sen University
University of Aarhus
National Cancer Institute (NCI)
Ontario Clinical Oncology Group (OCOG)
SWOG Cancer Research Network
University of Florida
Pharmacyclics LLC.